International Isotopes (INIS) versus Cognex (CGNX) Head-To-Head Comparison

International Isotopes (OTCMKTS:INIS) and Cognex (NASDAQ:CGNX) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations and risk.

Dividends

Cognex pays an annual dividend of $0.20 per share and has a dividend yield of 0.4%. International Isotopes does not pay a dividend. Cognex pays out 16.1% of its earnings in the form of a dividend. Cognex has raised its dividend for 9 consecutive years.

Profitability

This table compares International Isotopes and Cognex’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
International Isotopes -14.52% -303.53% -11.31%
Cognex 27.19% 19.75% 17.00%

Valuation and Earnings

This table compares International Isotopes and Cognex’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
International Isotopes $7.42 million 3.34 -$3.75 million N/A N/A
Cognex $806.34 million 10.85 $219.26 million $1.24 41.29

Cognex has higher revenue and earnings than International Isotopes.

Analyst Recommendations

This is a summary of recent ratings and target prices for International Isotopes and Cognex, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
International Isotopes 0 0 0 0 N/A
Cognex 1 5 5 0 2.36

Cognex has a consensus price target of $48.91, indicating a potential downside of 4.47%. Given Cognex’s higher probable upside, analysts plainly believe Cognex is more favorable than International Isotopes.

Risk and Volatility

International Isotopes has a beta of -0.4, meaning that its share price is 140% less volatile than the S&P 500. Comparatively, Cognex has a beta of 1.89, meaning that its share price is 89% more volatile than the S&P 500.

Institutional & Insider Ownership

89.2% of Cognex shares are held by institutional investors. 11.9% of International Isotopes shares are held by company insiders. Comparatively, 5.4% of Cognex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Cognex beats International Isotopes on 12 of the 14 factors compared between the two stocks.

About International Isotopes

International Isotopes, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt teletherapy sources, and radioisotopes and radiochemicals for medical research, pharmacy compounding, and clinical applications. The company operates in six segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services, and Transportation. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot markers, pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy or various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals for medical, industrial, and research applications. It provides iodine-131 radiochemical for use in the treatment and diagnosis of diseases of the thyroid gland, such as graves' disease, thyroid cancer, and hyperthyroidism, as well as for breast, lung, prostate, and ovarian cancers. The Fluorine Products segment offers products that are used to support the production and sale of gases produced using its fluorine extraction process. The Radiological Services segment decommissions disused irradiation units, performs sealed source exchanges in irradiation and therapy units, and processes gemstones. The Transportation segment provides transportation services for hazardous and non-hazardous cargo materials. The company sells its products directly to end users and distributors. International Isotopes, Inc. was founded in 1995 and is headquartered in Idaho Falls, Idaho.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. The company offers machine vision products, which are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. Its products include VisionPro, a software suite that provides various vision tools for programming; displacement sensors with vision software for use in 3D application; In-Sight vision systems that perform various vision tasks, including part location, identification, measurement, assembly verification, and robotic guidance; In-Sight vision sensors; ID products, including DataMan barcode readers and barcode verifiers, as well as vision-enabled mobile terminals for industrial barcode reading applications; and barcode scanning software development kits. The company sells its products to customers in the consumer electronics and automotive industries, and semiconductor and electronics capital equipment markets through direct sales force, as well as through a network of distributors and integrators. Cognex Corporation was founded in 1981 and is headquartered in Natick, Massachusetts.

Receive News & Ratings for International Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply